Clinical trials 18
0 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.
Randomized Phase II Study of Vorinostat or Placebo in Combination With Carboplatin and Paclitaxel for Patients With Advanced or Metastatic Non-Small Cell Lung Cancer
Recurrent Non-small Cell Lung Cancer · Stage IIIB Non-small Cell Lung Cancer · Stage IV Non-small Cell Lung Cancer
Enrolment: 94 · Results not recorded
Vorinostat and Concomitant Whole Brain Radiation Therapy in Patients With Brain Metastases: A Randomized, Double-blind, Placebo-controlled, Phase II Study
Brain Metastasis
Enrolment: 4 · Results not recorded
A Phase II Study of Vorinostat in Patients With Advanced Melanoma
Uveal Melanoma · Recurrent Melanoma · Stage IV Melanoma
Enrolment: 32 · Results not recorded
Selective Estrogen Receptor Modulators to Enhance the Efficacy of Viral Reactivation With Histone Deacetylase Inhibitors (Vorinostat)
HIV Infections
Enrolment: 31 · Results not recorded
Phase I/II Study of 5-azacitidine in Combination With Vorinostat in Patients With Relapsed or Refractory DLBCL
Lymphoma
Enrolment: 17 · Results not recorded
A Phase 1/2 Study of Vorinostat (SAHA) in Combination With Azacitidine in Patients With the Myelodysplastic Syndrome
Myelodysplastic Syndrome · Acute Myeloid Leukemia · Chronic Myelomonocytic Leukemia
Enrolment: 135 · Results not recorded
Phase I Trial of Chemoradiation With Capecitabine and Vorinostat in Pancreatic Cancer
Pancreatic Cancer · Periampullary Adenocarcinoma
Enrolment: 21 · Results not recorded
Phase I of Vorinostat-Iressa Combined Therapy on Resistance by BIM Polymorphysim in EGFR Mutant Lung Cancer
Non-Small-Cell Lung Carcinoma
Enrolment: 12 · Results not recorded
A Phase I Study of the mTOR Inhibitor Temsirolimus in Combination With the HDAC Inhibitor Vorinostat in Patients With Metastatic Prostate Cancer
Prostate Cancer · Adenocarcinoma of the Prostate · Hormone-resistant Prostate Cancer
Enrolment: 13 · Results not recorded
BMS CA180157: A Phase I Combination Study of Dasatinib Plus Vorinostat in Accelerated Phase, Chronic Phase Refractory to Second Line Therapy or Blast Crisis CML, and in Ph+ ALL
Leukemia
Enrolment: 5 · Results not recorded
A Phase I Clinical Trial of Vorinostat in Combination With Vinorelbine in Patients With Advanced Cancer
Malignant Solid Tumour
Enrolment: 30 · Results not recorded
A Window Trial of Vorinostat in Patients With Ductal Carcinoma in Situ (DCIS) of the Breast
Breast Cancer
Enrolment: 17 · Results not recorded
Randomized, Partially-Blind, Placebo-Controlled Crossover Study of the Effects of a Single Dose of Vorinostat on the QTc Interval in Patients With Advanced Cancer
Advanced Cancer Relapsed · Advanced Cancer Refractory
Enrolment: 25 · Results not recorded
Phase 1 Study of Paclitaxel and Carboplatin (With Vorinostat) in Solid Tumors in Persons With HIV Infection
HIV Infection · Recurrent Non-small Cell Lung Cancer · Stage IV Breast Cancer
Enrolment: 17 · Results not recorded
A Phase I Clinical Study of MK0683 (Vorinostat) in Patients With Malignant Lymphoma
Lymphoma
Enrolment: 10 · Results not recorded
Rett REVOLUTION Trial: Safety and Efficacy of Vorinostat in Rett Syndrome (N-of-1 Design)
Rett Syndrome
Enrolment: 15 · Results not recorded
Phase I Study of Induction Therapy With VELCADE and Vorinostat in Surgically Resectable Non-Small Cell Lung Cancer
Non Small Cell Lung Cancer
Enrolment: 21 · Results not recorded
A Phase IV Study Of The Impact Of Vorinostat On Cellular Signaling And Cytokine Production In Cutaneous T-Cell Lymphoma Patients With Pruritus
Pruritus
Enrolment: 0 · Results not recorded